Familial pulmonary fibrosis (FPF) is increasingly recognized as a distinct entity within the spectrum of interstitial lung diseases (ILDs), characterized by a significant genetic contribution involving genetic variation telomere-related genes, surfactant protein genes, and the <i>MUC5B</i> promoter polymorphism. This evidence concerns the gene MUC5B and TNF receptor 1-associated periodic fever syndrome.